Expression of p14 ARF, p15 INK4b, p16 INK4a and skp2 increases during esophageal squamous cell cancer progression

Authors

Peng Bai, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
Xue Xiao, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
Juan Zou, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
Lin Cui, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
Tri M. Bui-Nguyen, George Washington UniversityFollow
Jinsong Liu, George Washington University
Jianguo Xiao, George Washington University
Bin Chang, Shihezi University School of Medicine, Xinjiang, China
Jin Wu, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
He Wang, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, ChinaFollow

Document Type

Journal Article

Publication Date

6-2012

Journal

Experimental and Therapeutic Medicine

Volume

Volume 3, Issue 6

Inclusive Pages

1026-1032

Comments

This is a PubMed Central article. Click on link for full-text access.

APA Citation

Bai, P., Xiao, X., Zou, J., Cui, L., Bui Nguyen, T.M., Liu, J., Xiao, J., Chang, B., Wu, J., Wang, H. (2012). Expression of p14 ARF, p15 INK4b, p16 INK4a and skp2 increases during esophageal squamous cell cancer progression. Experimental and Therapeutic Medicine, 3(6), 1026-1032.

Peer Reviewed

1

Open Access

1